CHAM
ENZ

Clear Harbor Asset Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Clear Harbor Asset Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-40,000
Closed -$101K – 371
2020
Q4 		$101K Buy
+40,000
New +$87.1K 0.01% 291

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Clear Harbor Asset Management's ENZ Position: Q1 2021 in Review

Clear Harbor Asset Management sold out of Enzo Biochem, Inc. (ENZ) in Q1 2021, closing a stake of 40,000 shares — an estimated $101K sold.

Clear Harbor Asset Management first reported a position in ENZ in Q4 2020 and held it in 1 quarter. The position peaked at $101K in Q4 2020. 82 funds tracked by Wall St. Rank hold ENZ as of Q1 2021.

  • Clear Harbor Asset Management reported no remaining Enzo Biochem, Inc. position as of Q1 2021 after selling out during the quarter.
  • Clear Harbor Asset Management sold 40,000 Enzo Biochem, Inc. shares in Q1 2021, an estimated $101K.
  • Clear Harbor Asset Management first reported a position in Enzo Biochem, Inc. in Q4 2020 and held it in 1 quarter.
  • Clear Harbor Asset Management's Enzo Biochem, Inc. position peaked at $101K in Q4 2020.
  • 82 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2021.

Based on Clear Harbor Asset Management's 13F filing for Q1 2021, filed 14 Apr 2021.